These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 33256131)

  • 1. First Line Systemic Treatment for MALT Lymphoma-Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna.
    Kiesewetter B; Simonitsch-Klupp I; Mayerhoefer ME; Dolak W; Lukas J; Raderer M
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33256131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
    Kiesewetter B; Lamm W; Neuper O; Mayerhoefer ME; Simonitsch-Klupp I; Raderer M
    Hematol Oncol; 2019 Oct; 37(4):345-351. PubMed ID: 31283840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Kiesewetter B; Simonitsch-Klupp I; Dolak W; Mayerhoefer ME; Raderer M
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32093228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Status of the Spectrum and Therapeutics of
    Kuo SH; Yeh KH; Lin CW; Liou JM; Wu MS; Chen LT; Cheng AL
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205754
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma).
    Kiesewetter B; Raderer M
    Hematol Oncol; 2020 Oct; 38(4):417-424. PubMed ID: 32469432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
    Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
    Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
    Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
    Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
    Montalban C; Norman F
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kiesewetter B; Neuper O; Mayerhoefer ME; Dolak W; Lukas J; Simonitsch-Klupp I; Raderer M
    Hematol Oncol; 2018 Feb; 36(1):49-55. PubMed ID: 28695630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
    Kiesewetter B; Simonitsch-Klupp I; Kornauth C; Dolak W; Lukas J; Mayerhoefer ME; Raderer M
    Hematol Oncol; 2018 Feb; 36(1):62-67. PubMed ID: 28833354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and epigenetic mechanisms of gastric mucosa associated lymphoid tissue lymphoma and long-term follow-up following
    Song Y; Jiang K; Su S; Wang B; Chen G
    Exp Ther Med; 2018 Jan; 15(1):553-561. PubMed ID: 29387204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.
    Kiesewetter B; Troch M; Mayerhoefer ME; Dolak W; Simonitsch-Klupp I; Raderer M
    Oncologist; 2016 Jan; 21(1):72-5. PubMed ID: 26621040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.
    Kiesewetter B; Ferreri AJ; Raderer M
    Oncologist; 2015 Aug; 20(8):915-25. PubMed ID: 26156327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
    Wöhrer S; Drach J; Hejna M; Scheithauer W; Dirisamer A; Püspök A; Chott A; Raderer M
    Ann Oncol; 2003 Dec; 14(12):1758-61. PubMed ID: 14630681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
    Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
    Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
    Sugizaki K; Tari A; Kitadai Y; Oda I; Nakamura S; Yoshino T; Sugiyama T
    Helicobacter; 2018 Apr; 23(2):e12474. PubMed ID: 29504247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.